John Stanton

John Stanton is an accomplished engineering professional with extensive experience in the medical device and biotherapeutics sectors. Currently serving as the Associate Director of Sustaining Engineering at Mallinckrodt Pharmaceuticals since February 2018, John leads a team focused on maintaining the INOmax DSIR's commercial viability and facilitating new product introductions. Prior roles at Mallinckrodt include Manager of Sustaining Engineering and Lead Sustaining Engineer. John's career also encompasses engineering management and project management positions at nPoint, Inc., TomoTherapy, GE Healthcare, and Lunar, with a strong background in developing innovative technology and managing cross-functional teams. John holds an MBA from the Wisconsin School of Business and a degree from the University of Wisconsin-Madison.